Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Y A Sigidin"'
Autor:
M A Borisova, G V Lukina, Y A Sigidin, E S Aronova, E L Luchihina, D E Karateev, S V Glukhova, E L Nasonov
Publikováno v:
Терапевтический архив, Vol 90, Iss 5, Pp 44-49 (2018)
Objectives: This article reports 1-year clinical outcomes of patients with rheumatoid arthritis (RA) receiving abatacept (ABA) therapy. Materials and methods: Patients (n=91) with high RA activity (DAS28 = 5.1 ± 1.0) and an inadequate response on sy
Externí odkaz:
https://doaj.org/article/ae4a2c7819154f0fb9ecfccd58c800b9
Autor:
G V Lukina, Y A Sigidin
Publikováno v:
Научно-практическая ревматология, Vol 47, Iss 1, Pp 50-55 (2009)
Ревматоидный артрит (РА) – аутоиммунное ревматическое заболевание неизвестной этиологии, характеризующееся хроническим эрозивным арт
Externí odkaz:
https://doaj.org/article/4d1c011dd77a4e6cbaef810c94064741
Publikováno v:
Научно-практическая ревматология, Vol 46, Iss 4, Pp 36-40 (2008)
Externí odkaz:
https://doaj.org/article/c353fc05d2ea4d75a5d842ed67b565f7
Autor:
G. V. Lukina, Y A Sigidin
Publikováno v:
Научно-практическая ревматология, Vol 46, Iss 2, Pp 60-63 (2008)
Externí odkaz:
https://doaj.org/article/8e3180e0b10344d6a4929c2c0d126a63
Autor:
Y A Sigidin, G. V. Lukina
Publikováno v:
Научно-практическая ревматология, Vol 46, Iss 2, Pp 56-59 (2008)
Externí odkaz:
https://doaj.org/article/f566e26aeba34cc28456f16f143411e5
Publikováno v:
Научно-практическая ревматология, Vol 45, Iss 3, Pp 105-108 (2007)
Externí odkaz:
https://doaj.org/article/80fe0fbc9a9b47cfb93d7cee702cf7a3
Publikováno v:
Научно-практическая ревматология, Vol 43, Iss 5, Pp 64-66 (2005)
Externí odkaz:
https://doaj.org/article/182e40d4c06149e79ecc34a4cdf73c6b
Autor:
G V Lukina, Y A Sigidin
Publikováno v:
Научно-практическая ревматология, Vol 39, Iss 2, Pp 51-53 (2001)
Summary Aljlutup is an effective and well tolerable drug which not only decreases pains and other clinical manifestations of secondary synovitis but also has positive effect on the structure of articular cartilage.
Externí odkaz:
https://doaj.org/article/fb775a169c6245b3bbc79342bd900ada
Autor:
G. V. Lukina, Y. A. Sigidin, E. S. Posdnyakova, E. L. Luchihina, D. E. Karateev, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 45, Iss 4, Pp 60-65 (2016)
Objective. To assess efficacy and tolerability of infliximab in pts with rheumatoid arthritis (RA) in real clinical practice. Materials and methods. 75 RA pts with high disease activity according to DAS 28 in 80% who received previous antirheumatic d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48f379baabfa32ecf2411cbcb2c834f5
https://rsp.mediar-press.net/rsp/article/view/2189
https://rsp.mediar-press.net/rsp/article/view/2189
